lefamulin will boost the degree or result of sorafenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lefamulin is contraindicated with CYP3A substrates know to extend the QT interval. Every drug prolongs the QTc interval, which may improved the potential risk of Torsade de pointes, other severe arryhthmias, and sudden